Vice President, Cancer Biology

Omega Therapeutics is a development-stage biotechnology company pioneering a new class of programmable, mRNA-encoded therapeutics to transform human medicine. The OMEGA Epigenomic Programming™ platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cell genesis, growth and differentiation to cell death. The OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a normal range without altering native nucleic acid sequences. Omega's engineered, modular, and programmable mRNA-encoded epigenetic medicines, Omega Epigenomic Controllers™, target specific intervention points amongst the thousands of validated novel DNA-sequence-based epigenomic targets we have mapped to tune single or multiple genes to treat and cure disease through Precision Genomic Control™. Omega is currently advancing a broad pipeline of development candidates spanning a range of disease areas, including oncology, regenerative medicine, multigenic diseases including immunology, and select monogenic diseases.

About the Role:

Omega Therapeutics is seeking a Vice President, Cancer Biology, to lead the company's efforts in identifying, validating and rapidly translating novel and existing high-value oncology targets from concept into first-in-class therapeutics for Oncology. The ideal candidate will be independent, motivated, and work with a sense of urgency. She or he will efficiently lead strategic and operational aspects of projects, ensuring progression of multiple parallel projects, leading cross-functional teams and acting as a thought leader and resource in Oncology across the organization. We are searching for enthusiastic, innovative, and self-motivated individuals who are comfortable working in a fast-paced, entrepreneurial environment.

Responsibilities:

• Build and lead the development of Omega's Cancer Biology and Epigenetics function; setting research strategy and early clinical focus, leading target selection and evaluation, identifying and appropriate disease models; helping envision, implement and rapidly drive therapeutic programs forward through R&D
• Provide scientific leadership, expertise and management of translational efforts across programs and teams in a highly matrixed organization, ensuring and open communication and rapid execution
• Design and lead project research plans and discovery cascades, related assay development, in vitro proof-of-concept, in vivo translational studies, data analysis, interpretation, reporting, communicating progress to executive management, Board of Directors and external partners
• Lead innovative preclinical model development to enable interrogation and elucidation of mechanism of action, diagnostic hypotheses, mechanisms of resistance, and define PK/PD/efficacy relationships
• Manage and lead a cross-functional team while also mentoring project leaders, comfortably operating in a team-first environment
• Thoroughly understand corporate objectives to align project plans and priorities
• Contribute to regulatory filings, patent applications and manuscripts published in peer-reviewed journals

Required Qualifications:

• PhD or equivalent in biological sciences with significant experience advancing drug discovery projects into development in a pharmaceutical or biotech environment
• Deep understanding and industry experience in Oncology/Immuno-oncology, including translational research/medicine and early clinical development.
• Commitment to identifying simple, critical path discovery cascades and creating scalable, high quality experimental systems that can translate throughout a program's lifecycle
• Excellent leadership capabilities with at least 10 years biotech/biopharma industry experience in guiding and motivating successful teams, as well as building and managing productive research collaborations
• Very strong communication and partnering skills
• Demonstrated ability to lead and influence others in a matrixed work environment

Preferred Qualifications:

• Deep knowledge of cancer biology, chromatin and DNA/RNA biology, epigenetics and gene therapy/gene editing, including viral and non-viral delivery modalities, and advanced sequencing technologies
• Experience in metabolic, liver and regenerative disease, rare disease, hematological and immune disorders, inflammatory disease, neuromuscular or neurodegenerative disease with proven success and contribution to the field
• Experience in Research and Translational Development for biologics, nucleic acids macromolecules, advanced therapeutics, and cellular model systems

U.S. Equal Opportunity Employment Information (Completion is voluntary)

Individuals seeking employment at Omega Therapeutics are considered without regards to race, color, religion, national origin, age, sex, marital status, ancestry, physical or mental disability, veteran status, gender identity, or sexual orientation. You are being given the opportunity to provide the following information in order to help us comply with federal and state Equal Employment Opportunity/Affirmative Action record keeping, reporting, and other legal requirements.

Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.
Gender Please select Are you Hispanic/Latino? Please select Race & Ethnicity Definitions
If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.
Veteran Status Please select
Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023
Voluntary Self-Identification of DisabilityWhy are you being asked to complete this form?
We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor's Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp .
How do you know if you have a disability?
You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

• Autism
• Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
• Blind or low vision
• Cancer
• Cardiovascular or heart disease
• Celiac disease
• Cerebral palsy
• Deaf or hard of hearing
• Depression or anxiety
• Diabetes
• Epilepsy
• Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
• Intellectual disability
• Missing limbs or partially missing limbs
• Nervous system condition for example, migraine headaches, Parkinson's disease, or Multiple sclerosis (MS)
• Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

Disability Status Please select
1 Section 503 of the Rehabilitation Act of 1973, as amended. For more information about this form or the equal employment obligations of Federal contractors, visit the U.S. Department of Labor's Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp .

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.